Activest Wealth Management
RPRX icon

Activest Wealth Management’s Royalty Pharma RPRX Stock Holding History

Activest Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-17
Closed -$953 – 1316
2026
Q2 		$953 Buy
17
+16
+1,600% +$833 ﹤0.01% 967
2026
Q1 		$48 Buy
+1
New +$44 ﹤0.01% 1181

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Activest Wealth Management's RPRX Position: Q3 2026 in Review

Activest Wealth Management sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 17 shares — an estimated $953 sold.

Activest Wealth Management first reported a position in RPRX in Q1 2026 and held it in 2 quarters. The position peaked at $953 in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Activest Wealth Management reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Activest Wealth Management sold 17 Royalty Pharma shares in Q3 2026, an estimated $953.
  • Activest Wealth Management first reported a position in Royalty Pharma in Q1 2026 and held it in 2 quarters.
  • Activest Wealth Management's Royalty Pharma position peaked at $953 in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.